- Organigram’s
proprietary nano-emulsion technology is expected to provide an initial
onset of effects within 10 to 15 minutes for cannabis beverages
- The
company’s shelf-stable, thermally stable, water-compatible and palatable
cannabinoid nano-emulsion formulation allows for the production of both
liquid and powdered beverage products
- Organigram
plans to launch dried powder formulation beverage products in early 2020
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), the
parent company of leading licensed cannabis producer and cannabis-derived
products manufacturer Organigram Inc., has developed a proprietary
nano-emulsification technology. This new unique, fast-acting formulation will
allow for the production of both powdered and liquid cannabinoid products. The
development comes in the context of the much-anticipated legalization of adult
recreational-use cannabis edibles in Canada and the ensuing boost in demand, as
the company noted in a news release (http://ibn.fm/zy5Pt).
Organigram focuses on high-quality, indoor-grown cannabis
for both medical patients and adult recreational users. Its proprietary
technology allows for the development of products with a quick onset of the
cannabinoid effect within 10 to 15 minutes. To determine the onset of the
products, Organigram studied cannabinoid particles at a size of 20 nanometers.
Organigram’s nano-emulsion technology is stable to temperature variations,
mechanical disturbance, salinity, pH and sweeteners. Further testing is
anticipated to occur in order to confirm the onset of action and the duration
of the effect.
Previously, Organigram announced the launch of premium
cannabinoid-infused chocolates. The company will also be working toward the
release of additional dried powder formulation beverages in Canada in early
2020.
“This is an exciting time for cannabis product makers”,
Organigram CEO Greg Engel said in a news release. “To ensure the satisfaction
of adult consumers, companies have to deliver both predictability and
reliability. Organigram’s technology and the powdered formulation put the
customer in control, allowing them to infuse just about any beverage… This new
method of delivery allows for a completely new experience.”
At the same time, Organigram is also actively seeking a
partner with proven experience within the beverage market to take advantage of
the liquid formulation it has developed.
On July 10, Organigram announced a collaboration with Lift
& Co. Corp. (TSX.V: LIFT) (OTCQB: LFCOF), supporting the launch of Canada’s
first branded cannabis educational program (http://ibn.fm/KEQiK).
The program, developed in partnership with MADD Canada, aims
to promote the responsible sale of cannabis and will be available via the Lift
& Co. CannSell retail training program. Currently, CannSell is the only
mandatory, provincially approved cannabis training program for all Ontario
retail workers. Organigram is the first licensed cannabis producer in Canada to
partner up with Lift & Co. for the purpose of educational content creation.
The rollout of the branded Organigram module of the program
started in June 2019. The module will deliver digital training on Organigram’s
three-tiered growing methodology, as well as best practices.
“This module will allow Organigram to connect directly with
budtenders at any time and educate retail staff about their product attributes,
best practices and stay top-of-mind with budtenders – the only people in the
value chain speaking directly with consumers,” Lift & Co CEO Matei Olaru
added.
For more information, visit the company’s website at www.Organigram.ca
NOTE TO INVESTORS: The latest news and updates
relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
